Evidence map›Paper›PMID 29296400›Full record

ArticleJournal of radiosurgery and SBRT2015

Stereotactic radiosurgery to the resection cavity for brain metastases: prognostic factors and outcomes.

Ryan J Abel, Lingyun Ji, Cheng Yu, Ariel Lederman, Thomas Chen, Charles Liu, Gabriel Zada, Paul E Kim, Michael Apuzzo, Eric L Chang

Open access · greenAbstract read
In one paragraph

Article in Journal of radiosurgery and SBRT, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Current approaches to the management of brain metastases.Nature reviews. Clinical oncology · 2020
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Ryan J AbelKeck USC School of Medicine Department of Radiation Oncology,1441 Eastlake Avenue, Los Angeles, CA 90033, USA.
Lingyun JiUSC Department of Preventive Medicine, 1501 San Pablo Street, ZNI 101, Los Angeles CA 90033, USA.
Cheng YuKeck USC School of Medicine Department of Radiation Oncology,1441 Eastlake Avenue, Los Angeles, CA 90033, USA.
Ariel LedermanKeck School of Medicine of University of Southern California, 1975 Zonal Ave, Los Angeles, CA 90033, USA.
Thomas ChenKeck USC School of Medicine Department of Neurosurgery, 1520 San Pablo St. Suite 3800, Los Angeles, CA 90033, USA.
Charles LiuKeck USC School of Medicine Department of Neurosurgery, 1520 San Pablo St. Suite 3800, Los Angeles, CA 90033, USA.
Gabriel ZadaKeck USC School of Medicine Department of Neurosurgery, 1520 San Pablo St. Suite 3800, Los Angeles, CA 90033, USA.
Paul E KimKeck USC School of Medicine Department of Radiology, 1500 San Pablo Street, Second Floor Imaging, Los Angeles, CA 90033, USA.
Michael ApuzzoKeck USC School of Medicine Department of Neurosurgery, 1520 San Pablo St. Suite 3800, Los Angeles, CA 90033, USA.
Eric L ChangKeck USC School of Medicine Department of Radiation Oncology,1441 Eastlake Avenue, Los Angeles, CA 90033, USA.
Keck Hospital of USC · USUniversity of Southern California · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAdjuvant stereotactic radiosurgery (SRS) alone after surgical resection is increasingly being used to provide excellent local control while avoiding the side effects of whole brain radiation therapy (WBRT). We report our ten year experience using this treatment scheme. PURPOSE/

objectivesTo determine the rates and any correlates of local control, distant brain failure, and overall survival using SRS alone to the resection cavity. MATERIALS/

methodsWe performed a retrospective analysis of 509 patients with brain metastasis who underwent Gamma Knife SRS at our institution between 2003 and 2013. Of this group 85 patients were identified that had resection of the metastasis and subsequent SRS to the cavity. Mean dose to the resection cavity was 17.3 Gy (range 14-20) to an average volume of 12cc (range 0.3-83cc). Multiple patient, tumor, and treatment specific factors were collected for analysis (see Table 1). Vital statistics were provided by our institution's tumor registry. The primary endpoint of our analyses was recurrence free survival (RFS); defined as the duration in time between the date of SRS and any local or distant brain tumor recurrence.

resultsWith a median follow up of 16.4 months, the overall local and distant brain failure at 12 months was 13% (95%CI 5%-21%) and 51% (95%CI 37%-64%) respectively. RPA was class 1 (5%), 2 (75%), and 3 (20%). The median overall survival (OS) was 20 months. The median RFS was 24 months with radiosensitive tumors: non small cell lung cancer (n=12), breast (n=16), gastrointestinal (n=7), small cell lung cancer (n=1), and other (n=9) compared to 5.6 months (p=0.006) in radioresistant tumors: melanoma (n=33), sarcoma (n=1), and renal cell carcinoma (n=6). Median OS for radioresistant and radiosensitive patients was 12 vs 25 months respectively (p=0.11). Additionally, there was a significant improved survival difference seen amongst those who had a gross total resection (GTR, n=46) compared to a sub total resection (n=39) with median OS of 27 vs 16 months (p=0.020) respectively. Radiographic changes suggestive of radiation necrosis were present in 6 patients, 2 of which were determined histiopathologicaly after surgical intervention. Due to the limited number of local recurrence events (n=10), there was insufficient power to analyze prognostic factors for local recurrence.

conclusionsOur results compare favorably with multiple other institution experiences showing excellent local control with SRS to the resection cavity following resection. Radioresistant histologies were associated with a worse RFS. Patients undergoing GTR had a significantly longer OS than those with STR. At our institution we continue to offer patients SRS to the resection cavity for those with good performance status and limited brain metastases.

Indexed as

Brain MetastasesGammaKnifeResection CavityStereotactic Radiosurgery

Identifiers

PMID29296400
PMCPMC5746332
OpenAlexW1998915313

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.